Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Equity (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Return on Equity for 7 consecutive years, with 0.19% as the latest value for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.19% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.19% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.18% for FY2025, 1.0% up from the prior year.
  • Return on Equity hit 0.19% in Q4 2025 for Eton Pharmaceuticals, up from 0.28% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.13% in Q3 2023 to a low of 0.9% in Q2 2022.
  • Historically, Return on Equity has averaged 0.37% across 5 years, with a median of 0.33% in 2024.
  • Biggest five-year swings in Return on Equity: skyrocketed 487bps in 2021 and later tumbled -63bps in 2022.
  • Year by year, Return on Equity stood at 0.12% in 2021, then crashed by -533bps to 0.74% in 2022, then soared by 92bps to 0.06% in 2023, then crashed by -227bps to 0.19% in 2024, then increased by 1bps to 0.19% in 2025.
  • Business Quant data shows Return on Equity for ETON at 0.19% in Q4 2025, 0.28% in Q3 2025, and 0.17% in Q2 2025.